Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Opinion and Sentiment Analysis of Palliative Care in the Era of COVID-19.
Inoue M, Li MH, Hashemi M, Yu Y, Jonnalagadda J, Kulkarni R, Kestenbaum M, Mohess D, Koizumi N. Inoue M, et al. Among authors: kestenbaum m. Healthcare (Basel). 2023 Mar 14;11(6):855. doi: 10.3390/healthcare11060855. Healthcare (Basel). 2023. PMID: 36981512 Free PMC article.
The Influence of GBA and LRRK2 on Mood Disorders in Parkinson's Disease.
DeBroff J, Omer N, Cohen B, Giladi N, Kestenbaum M, Shirvan JC, Cedarbaum JM, Gana-Weisz M, Goldstein O, Orr-Urtreger A, Mirelman A, Thaler A. DeBroff J, et al. Among authors: kestenbaum m. Mov Disord Clin Pract. 2023 Mar 21;10(4):606-616. doi: 10.1002/mdc3.13722. eCollection 2023 Apr. Mov Disord Clin Pract. 2023. PMID: 37070047 Free PMC article.
Management of advanced Parkinson's disease in Israel: Clinicians viewpoint and action items.
Gurevich T, Arkadir D, Badarny S, Benizri S, Cohen O, Djaldetti R, Hassin-Baer S, Kestenbaum M, Nitsan Z, Zlotnik Y, Yahalom G. Gurevich T, et al. Among authors: kestenbaum m. Front Aging Neurosci. 2022 Oct 27;14:1029824. doi: 10.3389/fnagi.2022.1029824. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36389061 Free PMC article.
Carotid Web: An Occult Etiology of Stroke in the Young.
Gour A, Elefant E, Fanadka F, Kestenbaum M, Lev N. Gour A, et al. Among authors: kestenbaum m. Isr Med Assoc J. 2022 Aug;24(8):546-548. Isr Med Assoc J. 2022. PMID: 35972004 Free article. No abstract available.
Glucocerebrosidase Activity Is Not Associated with Parkinson's Disease Risk or Severity.
Omer N, Giladi N, Gurevich T, Bar-Shira A, Gana-Weisz M, Glinka T, Goldstein O, Kestenbaum M, Cedarbaum JM, Mabrouk OS, Fraser KB, Shirvan JC, Orr-Urtreger A, Mirelman A, Thaler A. Omer N, et al. Among authors: kestenbaum m. Mov Disord. 2022 Mar;37(3):651-652. doi: 10.1002/mds.28929. Epub 2022 Jan 22. Mov Disord. 2022. PMID: 35064687 No abstract available.
Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity.
Omer N, Giladi N, Gurevich T, Bar-Shira A, Gana-Weisz M, Glinka T, Goldstein O, Kestenbaum M, Cedarbaum JM, Mabrouk OS, Fraser KB, Shirvan JC, Orr-Urtreger A, Mirelman A, Thaler A. Omer N, et al. Among authors: kestenbaum m. Mov Disord. 2022 Jan;37(1):190-195. doi: 10.1002/mds.28792. Epub 2021 Sep 22. Mov Disord. 2022. PMID: 34550621 Free PMC article.
Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory Markers.
Thaler A, Omer N, Giladi N, Gurevich T, Bar-Shira A, Gana-Weisz M, Goldstein O, Kestenbaum M, Shirvan JC, Cedarbaum JM, Orr-Urtreger A, Regev K, Shenhar-Tsarfaty S, Mirelman A. Thaler A, et al. Among authors: kestenbaum m. J Parkinsons Dis. 2021;11(3):1285-1296. doi: 10.3233/JPD-212624. J Parkinsons Dis. 2021. PMID: 33998549 Free PMC article.
Biochemical markers for severity and risk in GBA and LRRK2 Parkinson's disease.
Thaler A, Omer N, Giladi N, Gurevich T, Bar-Shira A, Gana-Weisz M, Goldstein O, Kestenbaum M, Cedarbaum JM, Orr-Urtreger A, Shenhar-Tsarfaty S, Mirelman A. Thaler A, et al. Among authors: kestenbaum m. J Neurol. 2021 Apr;268(4):1517-1525. doi: 10.1007/s00415-020-10325-4. Epub 2021 Jan 3. J Neurol. 2021. PMID: 33388928
34 results